Brookdale Wave header-wave

Pricing & Availability

877-384-8989

What Older Adults Should Know About GLP-1s

About Laura Gooch

Laura Gooch, MFA, is a Content Specialist at Brookdale and a poet. She earned her BA in English from Pace University and an MFA in Creative Writing from Adelphi University. Laura uses her storytelling background to craft engaging blog and social media content. When she's not writing, she's reading voraciously, singing in her car, or spending time with her two wiener dogs.

What Are GLP-1 and Dual GIP/GLP-1 Medications?

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are medications that mimic glucagon-like peptide-1, a hormone your body naturally makes. They help lower blood sugar in people with type 2 diabetes and can reduce appetite and slow digestion. Some are also used for weight management.

Dual GIP/GLP-1 receptor agonists act on two gut hormone receptors: GLP-1 and glucose-dependent insulinotropic polypeptide (GIP). Tirzepatide is one example. It’s sold as Mounjaro for type 2 diabetes and Zepbound for chronic weight management. Zepbound is also FDA approved to treat moderate-to-severe obstructive sleep apnea in adults with obesity.

Benefits

Improved Metabolic Health

The number on the scale is only one part of your health. Metabolic health also includes how your body manages blood sugar, blood pressure and fats in the blood. GLP-1 and GIP are hormones that help your body regulate blood sugar after you eat. The medications that act on their receptors can improve blood sugar control alongside weight loss. In clinical trials of semaglutide and tirzepatide, participants also saw improvements in blood pressure and lipid levels compared to the placebo group.

If you have prediabetes, those changes may be particularly meaningful. A three-year clinical trial of adults with obesity and prediabetes found that 1.3% of participants taking tirzepatide developed type 2 diabetes, compared with 13.3% of participants taking a placebo. Tirzepatide lowered the risk of developing type 2 diabetes during the study, but researchers are still learning how long that benefit lasts after people stop taking the medication. Your healthcare provider can help you weigh those changes alongside how you feel and function each day.

Reduced Heart Disease Risk

Some GLP-1 medications may help protect the heart as well as support weight management and blood sugar control. A large clinical trial of 17,604 adults with overweight or obesity and existing cardiovascular disease found that those taking semaglutide were less likely to have a heart attack, stroke or death from cardiovascular causes than those who took the placebo. Over approximately three years, these cardiovascular events occurred in 6.5% of the semaglutide group and 8% of the placebo group. Participants did not have diabetes.

A meta-analysis of eleven randomized clinical trials found that GLP-1 medications reduced the risk of a major cardiovascular event by 15% among participants 65 and older. The evidence varies by medication type and by the participants studied.

In a trial of tirzepatide, a dual GIP/GLP-1 medication, cardiovascular outcomes were similar to those seen with dulaglutide, a GLP-1 medication that is FDA-approved to reduce the risk of major adverse cardiovascular events. The trial included people with type 2 diabetes and existing cardiovascular disease. It did not show that tirzepatide was better than dulaglutide at preventing heart attacks, strokes or cardiovascular death. If you have heart disease, ask your healthcare provider whether a medication with demonstrated heart benefits might be right for you.

Potential Risks

Muscle Loss

When people lose weight while taking a GLP-1 medication, most of the weight lost is fat, but some is lean body mass. A drop in lean body mass does not necessarily mean someone has grown weaker, but strength matters, especially as you age. Significant loss of muscle and strength can affect mobility and quality of life, making everyday activities harder. It’s also associated with poorer metabolic health, a higher risk of serious health problems and the potential loss of independence. That’s why it helps to pay attention to how you’re moving and feeling during weight loss, not just focusing on the number on the scale.

Combining resistance exercise and adequate protein intake can help limit muscle loss and maintain strength during weight loss. If you’re taking one of these medications, ask your healthcare provider what kind of activity and nutrition plan you should consider implementing. Older adults who are frail or already have low muscle mass should ask whether baseline and follow-up checks of strength and physical function, plus individualized nutrition or dietitian support, are appropriate.

Bone Density Decline

Bone density often declines with age as the body loses bone faster than it replaces it. For many women, bone loss accelerates after menopause. In 2017-2018, 43.1% of Americans aged 50 and older had low bone mass, also known as osteopenia, which increases the risk of osteoporosis. Because substantial weight loss can also reduce bone density, researchers are examining what GLP-1 medications and dual GIP/GLP-1 medications may mean for bone health.

Because these medications can reduce appetite and food intake, some people may have difficulty meeting protein and micronutrient needs during weight loss. Older adults should ask whether their intake, weight-loss rate and nutritional status need monitoring and whether referral to a registered dietitian would help.

Strength training, including resistance training and weight-bearing exercises, may help preserve bone density and strength during weight loss. If you’re concerned about bone loss, speak with your healthcare provider about your fracture risk and whether a bone density test makes sense for you.

Side Effects and Drug Interactions

Like any medication, GLP-1 and dual GIP/GLP-1 medications can cause side effects. Knowing what to expect can help you and your healthcare provider decide whether one is right for you. Possible side effects include:

  • Nausea or vomiting
  • Diarrhea or constipation
  • Loss of appetite
  • Dizziness or headaches
  • A mildly increased heart rate

Before starting treatment, give your healthcare provider or pharmacist a list of all prescription medicines, over-the-counter medicines and supplements. Taking a GLP-1 or dual GIP/GLP-1 medication with insulin or a sulfonylurea can increase the risk of low blood sugar (hypoglycemia). Because these medications delay stomach emptying, they may affect the absorption of oral medicines; FDA labeling advises monitoring medicines that require precise blood levels. Any medication changes should be guided by your healthcare provider.

What Happens If You Discontinue Your Medication?

It’s important to consider your long-term care plan before starting any treatment and lifestyle changes. A follow-up to a semaglutide trial found that participants regained, on average, about two-thirds of the weight they had lost in the year after stopping semaglutide and the trial’s lifestyle support. A separate tirzepatide trial also found that participants who discontinued treatment regained weight, while those who continued generally maintained their weight loss or lost additional weight. While these findings are specific to the people, medications and lifestyle interventions studied, it’s important to talk with your healthcare provider about how long you might take the medication and what support is available if you stop.

Cost and Insurance Coverage

Cost and prescription drug coverage can play an important role in long-term care planning. A 2025 KFF poll found that 56% of people who had taken a GLP-1 said it was difficult to afford. If you have Medicare, coverage depends on the medication and why it was prescribed. The Medicare GLP-1 Bridge runs from July 1, 2026, through December 31, 2027, and offers certain eligible Part D beneficiaries a $50 copay when an included drug is prescribed for weight management and clinical criteria are met. Prescriptions for Part D-covered indications — such as type 2 diabetes, moderate-to-severe obstructive sleep apnea or qualifying noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) — go through the person’s Part D plan rather than the Bridge. Before starting, confirm eligibility, prior-authorization requirements and monthly out-of-pocket cost.

GLP-1 and dual GIP/GLP-1 medications can offer significant medical benefits, but the right choice depends on your health, goals and ability to continue treatment. If you’re considering one, speak with your healthcare provider about your expectations, what complementary lifestyle changes you’ll need to make to support your strength and nutrition and how you’ll know if the medication is working for you. Be sure to work closely with your healthcare provider to design the right care plan for you.

The above content is shared for educational and informational purposes only. You must consult your doctor before beginning any diet, exercise, or fitness program, taking any additional or discontinuing any existing medications, or otherwise acting on any content on this website, especially if you have a medical condition. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on our site.


Inside Brookdale Communities

See what’s happening on our community Instagram pages

Brookdale has communities near you!
Find a Brookdale Community Near You
Find a Brookdale Community Near You
Chat Now